Drug class
Cerebral Vasodilators
Cerebral vasodilators are a broad functional category of pharmacologic agents that promote the relaxation of vascular smooth muscle within intracranial arteries and arterioles to augment cerebral blood flow and reduce cerebrovascular resistance. Read more about Cerebral Vasodilators
9 drugs in this class 8 manufacturers
Drugs in Cerebral Vasodilators
NIMODIPINE
NIMODIPINE
NIMODIPINE
NYMALIZE (nimodipine)
NYMALIZE (nimodipine)
NIMODIPINE
NYMALIZE (nimodipine)
NIMODIPINE
Cerebral vasodilators are a broad functional category of pharmacologic agents that promote the relaxation of vascular smooth muscle within intracranial arteries and arterioles to augment cerebral blood flow and reduce cerebrovascular resistance.
Rather than representing a single molecular class, they encompass diverse drug mechanisms—including calcium channel antagonists, phosphodiesterase inhibitors, and direct-acting vascular smooth muscle relaxants—that target cerebrovascular hemodynamics.
Historically investigated to improve cognitive decline and chronic cerebrovascular insufficiency, cerebral vasodilating agents in modern clinical practice are primarily indicated or utilized to prevent and relieve cerebral vasospasm associated with aneurysmal subarachnoid hemorrhage, stroke, or severe cerebral small vessel disease.
-
nih.gov
Cerebral vasodilators are a broad functional category of pharmacologic agents that promote the relaxation of vascular smooth muscle within intracranial arteries and arterioles to augment cerebral blood flow and reduce cerebrovascular resistance
-
nih.gov
Cerebral vasodilators are a broad functional category of pharmacologic agents that promote the relaxation of vascular smooth muscle within intracranial arteries and arterioles to augment cerebral blood flow and reduce cerebrovascular resistance
-
nih.gov
Rather than representing a single molecular class, they encompass diverse drug mechanisms—including calcium channel antagonists, phosphodiesterase inhibitors, and direct-acting vascular smooth muscle relaxants—that target cerebrovascular hemodynamics Historically investigated to improve cognitive decline and chronic cerebrovascular insufficiency, cerebral vasodilating agents in modern clinical practice are primarily indicated or utilized to prevent and relieve cerebral vasospasm associated with ...
-
nih.gov
Rather than representing a single molecular class, they encompass diverse drug mechanisms—including calcium channel antagonists, phosphodiesterase inhibitors, and direct-acting vascular smooth muscle relaxants—that target cerebrovascular hemodynamics
-
nih.gov
Historically investigated to improve cognitive decline and chronic cerebrovascular insufficiency, cerebral vasodilating agents in modern clinical practice are primarily indicated or utilized to prevent and relieve cerebral vasospasm associated with aneurysmal subarachnoid hemorrhage, stroke, or severe cerebral small vessel disease
-
nih.gov
Historically investigated to improve cognitive decline and chronic cerebrovascular insufficiency, cerebral vasodilating agents in modern clinical practice are primarily indicated or utilized to prevent and relieve cerebral vasospasm associated with aneurysmal subarachnoid hemorrhage, stroke, or severe cerebral small vessel disease
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.